MedTrace Logo

The First-line Combined Chemotherapy for Advanced Gastric Cancer: A Prospective Observational Clinical Study

NCT02583659 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2015-11-11

No results posted yet for this study

Summary

This prospective cohort study aims to observe the efficacy and safety of the first-line combined chemotherapy for advanced gastric cancer(AGC) in Chinese population.

Conditions

Sponsors & Collaborators

  • Huazhong University of Science and Technology

    lead OTHER

Principal Investigators

  • Xianglin Yuan, MD,PHD · Tongji Hospital

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2016-06-30
Completion
2018-01-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02583659 on ClinicalTrials.gov